Stocks Health care NXGL
NASDAQ · Health careNexgel, Inc. (NXGL)
Nexgel, Inc. brought in $12.1M of revenue over the twelve months to June 30, 2026, up 3.4% from a year earlier. It posted a net loss of $6.2M. In fiscal 2025 capital spending exceeded operating cash flow by $1.4M. At June 30, 2026 it held $1.7M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 17, 2026.
Watch NXGL in 60 secondsWhat Nexgel, Inc. does
Nexgel, Inc. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker NXGL.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $11.4M | -$3M | -$0.38 | -$1.4M |
| 2024 | $8.7M | -$3.3M | -$0.50 | -$4.3M |
| 2023 | $4.1M | -$3.2M | -$0.56 | -$3.9M |
| 2022 | $2M | -$4.7M | -$0.85 | -$3.1M |
| 2021 | $1.6M | -$4.3M | -$1.45 | -$3M |
| 2020 | $674K | -$2.3M | -$1.05 | -$2.1M |
Full financial statements: income, balance sheet and cash flow
Where NXGL ranks in Health care
Latest SEC filings
What Nexgel, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 24, 2026
- September 23, 2026
- August 24, 2026Proxy statement DEF 14A
- August 21, 2026
- August 20, 2026IPO registration S-1
- August 17, 2026
- August 17, 2026Quarterly report 10-Q · period to June 30, 2026Revenue rose 28% to $3.7M versus the same quarter last year; diluted EPS -$0.40 versus -$0.09.
- August 17, 2026Late quarterly report notice NT 10-Q
- August 14, 2026Preliminary proxy statement PRE 14A
- August 5, 2026
Insider trades
What the people running Nexgel, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider trades were reported in the last 90 days.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| June 23, 2026 | Levy Adam R.Chief Executive Officer, Director | Sold | 5,000 | $3K |
| June 18, 2026 | Levy Adam R.Chief Executive Officer, Director | Sold | 6,000 | $3.6K |
| June 11, 2026 | Levy Adam R.Chief Executive Officer, Director | Sold | 3,000 | $1.8K |
| June 8, 2026 | Levy Adam R.Chief Executive Officer, Director | Sold | 3,000 | $1.6K |
| June 4, 2026 | Levy Adam R.Chief Executive Officer, Director | Sold | 3,000 | $1.8K |
| June 1, 2026 | Levy Adam R.Chief Executive Officer, Director | Sold | 2,000 | $1.2K |
| May 29, 2026 | Levy Adam R.Chief Executive Officer, Director | Sold | 3,000 | $1.8K |
| May 28, 2026 | Levy Adam R.Chief Executive Officer, Director | Sold | 7,000 | $4.2K |
| May 27, 2026 | Levy Adam R.Chief Executive Officer, Director | Sold | 3,000 | $1.8K |
Who owns NXGL
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Asymmetry Point LP13G, passive with 2 related filers | 8.8% | April 29, 2026 |
Largest institutional holders
Insiders
1 insiders reported holding 322,692 shares in total, about $56.1K at the last price.
| Holder | Shares |
|---|---|
| Levy Adam R.Chief Executive Officer, Director | 322,692 |
Questions about NXGL
What does Nexgel, Inc. do?
Nexgel, Inc. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker NXGL.
Is Nexgel, Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $6.2M on revenue of $12.1M.
How much revenue does Nexgel, Inc. make?
Over the twelve months to June 30, 2026 Nexgel, Inc. reported revenue of $12.1M. That is 3.4% more than a year earlier.
When did Nexgel, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 17, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the investor disclosure from September 24, 2026.
Similar companies
Compare NXGL with
Follow NXGL
Get an email when Nexgel, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow NXGL: get an email when it filesWhere the numbers come from
Financial figures are the values Nexgel, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.